PurGenesis Initiates Phase 2a Trial for the Treatment of Mild-to-Moderate Distal Ulcerative Colitis
MONTMAGNY, QC, June 10 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser.
http://smr.newswire.ca/en/purgenesis-technologies/purgenesis-initiates-phase-2a-trial
SOURCE PURGENESIS TECHNOLOGIES
Share this article